| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
CinacalcetPTH (Hyperparathyreoidism Sekundaer)Vitamin DKidney (Chronic renal failure)PTH (Hyperparathyreoidism BASKET)BisphosphonatesRaloxifene| 1 | 2007 | The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation. | 
| + | - | nl | Health Technol Assess 11(18):iii, xi-xiii, 1-167 (2007) |
| 2 | 2009 | Cinacalcet hydrochloride in chronic kidney disease-mineral bone disorder. |
| + | - | nl | Clin J Am Soc Nephrol 4(9):1405-8 (2009) Yokoyama K |
| 3 | 2009 | Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives. |
| + | - | nl | Clin J Am Soc Nephrol 4(1):234-41 (2009) |
| 4 | 2008 | Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results. |
| + | - | nl | Clin J Am Soc Nephrol 3(6):1718-25 (2008) |
| 5 | 2009 | Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006. |
| + | - | nl | Clin J Am Soc Nephrol 4(2):354-60 (2009) |
| 6 | 2008 | Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients. |
| + | - | nl | Nephrol Dial Transplant 23(1):328-35 (2008) |
| 7 | 2009 | Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. |
| + | - | nl | J Clin Endocrinol Metab 94(2):373-81 (2009) |
| 8 | 2011 | A novel dose regimen of cinacalcet in the treatment of severe hyperparathyroidism in hemodialysis patients. |
| + | - | nl | Saudi J Kidney Dis Transpl 22(3):448-55 (2011) |
